natgillin/translations-raw huggingface dataset:
High temperature (fever).
Zvišana telesna temperatura (vročina).
high temperature or fever
visoka telesna temperatura,
high temperature skin rash
visoka telesna temperatura, izpuščaj na koži.
high temperature symptoms after stopping the medicine
visoka temperatura simptomi po prenehanju jemanja zdravila
high temperature, chills, breathing difficulties
zvišana telesna temperatura, mrzlica, težave z dihanjem
High temperature.
zasoplost zvišana telesna temperatura.
High tumour burden was defined as at least one lesion ≥5 cm in diameter or 3 lesions ≥3 cm.
Veliko tumorsko breme je bilo opredeljeno kot vsaj ena lezija s premerom 5 cm ali več ali 3 lezije, velike 3 cm ali več.
High uric acid
Visoka raven sečne kisline10
High uric acid 10
Visoka raven
High uric acid 10
Visoka raven sečne
High uric acid 10
zvišan celokupni bilirubin
high uric acid level in the urine (hyperuricosuria) high uric acid level in the blood (hyperuricemia).
visoka raven sečne kisline v urinu (hiperurikozurija), visoka raven sečne kisline v krvi (hiperurikemija).
High uric acid levels in the blood;
visoke ravni sečne kisline v krvi
High Uric Acid10
sečne kisline10
High viral load
virusno breme
High viral load
Visoko
High viral load
visoko virusno
High viral load
visoko virusno breme
High-density polyethylene (HDPE) bottle label for 56 x 0.5 mg varenicline film-coated tablets
Nalepka za plastenko iz polietilena velike gostote (HDPE) s 56 filmsko obloženimi tabletami po 0,5 mg vareniklina
High-density polyethylene (HDPE) bottle label for 56 x 1 mg varenicline film-coated tablets
Nalepka za plastenko iz polietilena velike gostote (HDPE) s 56 filmsko obloženimi tabletami po 1 mg vareniklina
High-density polyethylene (HDPE) bottle packaging for 56 x 0.5 mg varenicline film-coated tablets
Pakiranje s plastenko iz polietilena velike gostote (HDPE) s 56 filmsko obloženimi tabletami po 0,5 mg vareniklina
High-density polyethylene (HDPE) bottle packaging for 56 x 1 mg varenicline film-coated tablets
Pakiranje s plastenko iz polietilena velike gostote (HDPE) s 56 filmsko obloženimi tabletami po 1 mg vareniklina
High-density polyethylene (HDPE) bottle with a polypropylene child-resistant closure.
Plastenka iz polietilena visoke gostote (HDPE) z za otroke varno polipropilensko zaporko.
High-density polyethylene (HDPE) bottle with child resistant closure containing 42, 60, 84, 90 or 120 hard capsules.
Plastenka iz polietilena visoke gostote (HDPE) z za pred posegom otrok varno zaporko, ki vsebuje 42, 60, 84, 90 ali 120 trdih kapsul.
High-density polyethylene (HDPE) bottle with child resistant closure containing 42, 60, 84, 90 or 120 tablets.
Plastenka iz polietilena visoke gostote (HDPE) z za pred posegom otrok varno zaporko, ki vsebuje 42, 60, 84, 90 ali 120 tablet.
High-density polyethylene (HDPE) bottle with child resistant polypropylene closure.
Plastenka iz polietilena velike gostote (HDPE) z zaporko iz polipropilena, varno za otroke.
High-density polyethylene (HDPE) bottle with polypropylene child resistant closure and an aluminium foil / polyethylene induction seal containing 56 x 0.5 mg film-coated tablets
Plastenka iz polietilena velike gostote (HDPE) s polipropilensko, za otroke varno zaporko, indukcijsko zapečaten z aluminijasto folijo/polietilenom, ki vsebuje 56 filmsko obloženih tablet po 0,5 mg.
High-density polyethylene (HDPE) bottle with polypropylene child resistant closure and an aluminium foil / polyethylene induction seal containing 56 x 1 mg film-coated tablets
Plastenka iz polietilena velike gostote (HDPE) s polipropilensko, za otroke varno zaporko, indukcijsko zapečaten z aluminijasto folijo/polietilenom, ki vsebuje 56 filmsko obloženih tablet po 1 mg.
High-density polyethylene bottles with rubber stopper and aluminium cap
plastenke iz polietilena visoke gostote, z nitrilnim gumijastim zamaškom in aluminijasto zaporko
High-density polyethylene portable bottle of 1000 ml containing 980 ml of the oral solution.
Prenosna plastenka iz polietilena visoke gostote po 1000 ml z 980 ml peroralne raztopine.
High-density polyethylene portable bottle of 500 ml containing 490 ml of the oral solution.
Prenosna plastenka iz polietilena visoke gostote po 500 ml s 490 ml peroralne raztopine.
high-dose ritonavir (an HIV medicine) certain medicines that enhance the breakdown of isavuconazole in the body (strong inducers of CYP3A4/5, see the package leaflet).
visokoodmerni ritonavir (zdravilo proti virusu HIV); določena zdravila, ki pospešujejo razgradnjo izavukonazola v telesu (močni induktorji CYP3A4/5; glejte navodilo za uporabo).
High-dose Yervoy (10 mg per kg body weight) or placebo (a dummy treatment) was added to standard treatment with dacarbazine, another cancer medicine.
V tej študiji so standardnemu zdravljenju z dakarbazinom (drugim zdravilom proti raku) dodajali visok odmerek zdravila Yervoy (10 mg na kg telesne mase) ali placebo (zdravilo brez zdravilne učinkovine).
High-RiSk AcUte Coronary Syndrome Patients] study, a comparison of ticagrelor combined with ASA to ASA therapy alone.
High-RiSk AcUte Coronary Syndrome Patients], ki je primerjala ticagrelor v kombinaciji z ASA z uporabo ASA same.
Higher
Večje
Higher antibody levels (≥ 65610 Dilution Fraction) will be compared with the subject’s urinary GAG values with a view to assess potential impacts on efficacy.
Višje ravni protiteles (≥ 65610 frakcije redčenja (DF – dilution fraction)) bodo primerjane z vrednostmi GAG v urinu tega bolnika z namenom oceniti morebitni vpliv na učinkovitost.
Higher Cavg (~50%), reduced peak trough fluctuation (Cmax/Cmin) and a longer Tmax were seen for Envarsus when compared with both, tacrolimus immediate-release formulation (Prograf) and a tacrolimus once daily formulation (Advagraf).
Pri zdravilu Envarsus so opazili večji Cavg (~ 50 %), zmanjšano spodnjo mejo največje fluktuacije (Cmax/Cmin) in daljši Tmax tako v primerjavi s takrolimusom s farmacevtsko obliko s takojšnjim sproščanjem (zdravilo Prograf) kot s takrolimusom s farmacevtsko obliko enkrat na dan (zdravilo Advagraf).
Higher degrees of clinical response (ACR50 and ACR70) were observed in all infliximab groups at 30 and 54 weeks compared with methotrexate alone.
30. in 54. tednu v vseh skupinah, ki so prejemale infliksimab, v primerjavi z bolniki, ki so prejemali le metotreksat.
Higher degrees of clinical response (ACR50 and ACR70) were observed in all infliximab groups at 30 and 54 weeks compared with methotrexate alone.
54. tednu opažali v vseh skupinah, ki so prejemale infliksimab, v primerjavi z bolniki, ki so prejemali le metotreksat.
Higher dosages up to 4g (including re-application and treatment of more than a single bleeding site) may be needed.
Morda bodo potrebni večji odmerki do 4 g (vključno s ponovnim nanosom in zdravljenjem več mest krvavitev).
Higher doses might be justified in some clinical circumstances.
Višje doze so lahko upravičene v nekaterih kliničnih okoliščinah.
higher doses of
indicirano, uporabite
Higher doses of Glivec and paracetamol have not been studied.
Večjih odmerkov zdravila Glivec in paracetamola niso proučevali.
Higher doses of imatinib and paracetamol have not been studied.
Večjih odmerkov imatiniba in paracetamola niso proučevali.
Higher doses of imatinib and paracetamol have not been studied.
Večjih odmerkov imatinibain paracetamola niso proučevali.
Higher doses of imatinib and paracetamol have not been studied.
Višjih odmerkov imatiniba in paracetamola niso proučevali.
Higher doses of ritonavir have been shown to be associated with an increased incidence of adverse events.
Za višje odmerke ritonavirja se je izkazalo, da so povezani s povečano pojavnostjo neželenih dogodkov.
Higher doses of the product, typically  1 ml/kg, resulted in more severe signs including unresponsiveness and occasionally death.
Večji odmerki zdravila, praviloma  1 ml/kg, so povzročili hujše znake, vključno z neodzivnostjo in, občasno, s smrtjo.
Higher doses should not be used.
Višji odmerek se ne sme uporabiti.
Higher exposure to afatinib has been observed in female patients, patients with lower body weight and those with underlying renal impairment (see section 5.2).
Pri ženskah, bolnikih z manjšo telesno maso in bolnikih z obstoječo ledvično okvaro so ugotovili večjo izpostavljenost afatinibu (glejte poglavje 5.2).
Higher frequencies in the Cotellic plus vemurafenib arm were observed for cerebral haemorrhage (1% vs 0%), gastrointestinal tract haemorrhage (4% vs 1%), reproductive system haemorrhage (2% vs <1%) and haematuria (3% vs 1%).
V skupini z zdravilom Cotellic in vemurafenibom so bile pogostejše: možganske krvavitve (1 % v primerjavi z 0 %), krvavitve v prebavilih (4 % v primerjavi z 1 %), krvavitve v reproduktivnih organih (2 % v primerjavi z 1 %) in hematurija (3 % v primerjavi z < 1 %).
Higher IC50 values for influenza B, up to a median of 8.5 nM, have been observed in published studies.
V objavljenih študijah so za virus influence B poročali tudi o višjih vrednostih IC50, do mediane 8,5 nM.
Higher incidences were also noted for infections with Grade ≥ 3 neutropenia (24% versus 19% in Block 1 and 22% versus 11% in Block 2), increased ALT (17% versus 8% in
Večja je bila tudi pojavnost okužb z nevtropenijo stopnje ≥ 3(24% proti 19% v 1.sklopu in 22% proti 11% v 2.sklopu), povečane koncentracije ALT (17% proti 8% v 2. sklopu), hipokaliemije (18% proti 6% v 1. sklopu in 21% proti
Higher incidences were also noted for infections with Grade ≥ 3 neutropenia (24% versus 19% in Block 1 and 22% versus 11% in Block 2), increased ALT (17% versus 8% in Block 2), hypokalaemia (18% versus
Večja je bila tudi pojavnost okužb z nevtropenijo stopnje ≥ 3 (24% proti 19% v 1. sklopu in 22% proti 11% v 2. sklopu), povečane koncentracije ALT (17% proti 8% v 2. sklopu), hipokaliemije (18% proti 6% v 1. sklopu in
Higher incidences were also noted for infections with Grade ≥ 3 neutropenia (24% versus 19% in Block 1 and 22% versus 11% in Block 2), increased ALT (17% versus 8% in Block 2), hypokalaemia (18% versus
Večja je bila tudi pojavnost okužb z nevtropenijo stopnje ≥ 3(24% proti 19% v 1.sklopu in 22% proti 11% v 2.sklopu), povečane koncentracije ALT (17% proti 8% v 2. sklopu), hipokaliemije (18% proti 6% v
Higher incidences were also noted for infections with Grade ≥ 3 neutropenia (24% versus 19% in Block 1 and 22% versus 11% in Block 2), increased ALT (17% versus 8% in Block 2), hypokalaemia (18% versus
Večja je bila tudi pojavnost okužb z nevtropenijo stopnje ≥ 3(24% proti 19% v 1.sklopu in 22% proti 11% v 2.sklopu), povečane koncentracije ALT (17% proti 8% v 2. sklopu), hipokaliemije (18% proti 6% v 1. sklopu in
Higher mean clearance, lower mean AUC, and lower mean Cmax were observed in 5 patients who tested positive for inhibition of cellular uptake of enzyme.
Višjo povprečno vrednost klirensa CL, nižjo povprečno vrednost AUC∞ in nižjo povprečno vrednost Cmax so opazili pri 5 bolnikih s pozitivnim testom na zaviranje privzema encimov v celice.
Higher mean patient global satisfaction scores, indicating a higher level of overall satisfaction, were seen in the ingenol mebutate groups compared to the vehicle groups (p<0.001) as measured by the Treatment Satisfaction Questionnaire for Medication (TSQM).
Višje povprečne rezultate splošnega zadovoljstva bolnikov, ki nakazujejo na višjo stopnjo splošnega zadovoljstva, so glede na rezultate vprašalnika o zadovoljstvu z zdravljenjem z zdravilom (TSQM – Treatment Satisfaction Questionnaire for Medication) dosegali bolniki v skupini z ingenol mebutatom v primerjavi s skupino z vehiklom (p < 0,001).
higher risk of getting infections especially from the devices used to give you the medicine, blood or gut infections
večje tveganje za okužbe povzročen s pripomočki za dajanje zdravila, okužbe krvi oziroma črevesja
Higher tenofovir concentrations
Večja koncentracija tenofovirja bi
Higher tenofovir concentrations could potentiate tenofovir associated adverse events, including renal disorders.
neželene učinke, vključno z ledvičnimi motnjami.
Higher than normal levels of eosinophils, a type of white blood cell (eosinophilia);
povišana raven eozinofilcev, vrste belih krvnih celic (eozinofilija)
higher than normal platelet counts (thrombocytosis); anaemia.
število trombocitov, večje od normalnega (trombocitoza), anemija.
Highest concentration levels are found in the fat.
Najvišje koncentracije je mogoče najti v maščevju.
Highest maintenance dose
Največji vzdrževalni odmerek
Highest total dose in clinical trials
Največji skupni odmerek v kliničnih študijah
highly active and progressive rheumatoid arthritis in adults who have not previously been treated with methotrexate; moderate to severe active polyarticular juvenile idiopathic arthritis (a rare childhood disease causing inflammation of many joints) in adolescents and children from six years of age who have not had a sufficient response to other medicines including at least one TNF blocker.
močno aktivnega in napredujočega revmatoidnega artritisa pri odraslih, ki se niso predhodno zdravili z metotreksatom; zmernega do hudega poliartikularnega juvenilnega idiopatskega artritisa (redke otroške bolezni, ki povzroča vnetje več sklepov) pri mladostnikih in otrocih, starejših od šest let, ki se niso zadostno odzvali na druga zdravila, med drugim na vsaj en zaviralec TNF.
Highly Emetogenic Chemotherapy Regimen
Zelo emetogena kemoterapija
High­risk cardiovascular patients were excluded from the trials and the incidence rates of serious major cardiovascular events in the trials were low (6.02 per 1,000 patient years in liraglutide­treated patients and 10.45 in all­comparator­treated patients), precluding firm conclusions.
Incidenčni deleži pomembnih srčno-žilnih resnih neželenih dogodkov v preskušanjih so bili majhni (6,02 na 1000 bolnik-let med bolniki, zdravljenimi z liraglutidom, in 10,45 med bolniki, zdravljenimi s primerjalnimi učinkovinami), kar pomeni, da trdnih zaključkov ne moremo postaviti.
hingles (herpes zoster)
pasovec (herpes zoster),
hingles (localised including around the eyes or spread across the body)
opazite pasasti izpuščaj (lokaliziran, vključno s področjem okoli oči ali razširjen po telesu),
hingles (localised including around the eyes or spread across the body)
pasasti izpuščaj (herpes zoster (lokaliziran, vključno s predelom okoli oči, ali razširjen po telesu))
hingles (localised including around the eyes or spread across the body)
če opazite pasasti izpuščaj (lokaliziran, vključno s predelom okoli oči ali razširjen po telesu),
hingles (localized including around the eyes or spread across the body)
pasasti izpuščaj (herpes zoster (lokaliziran, vključno s predelom okoli oči ali razširjen po telesu))
hingles cold sores.
pasovec, ocvirki.
hingles  feeling weak and unwell
pasasti izpuščaj  občutek šibkosti in slabo počutje
hingles, chickenpox, cold sore, swollen or enlarged glands
nožnici, pasovec, norice, herpes na ustnicah, otekle ali povečane bezgavke
hingles, flu-like symptoms
pasovec, gripi podobni simptomi
hip flank (your side, between your ribs and your hip).
kolk, bok (med rebri in kolkom).
Hip fracture surgery
Operacija kolčnega zloma
Hiprabovis IBR Marker Live is a vaccine that contains an IBR virus that has been genetically modified to delete two genes so that the virus is less ‘pathogenic’ (less able to cause a disease).
Zdravilo Hiprabovis IBR Marker Live je cepivo, ki vsebuje genetsko spremenjen virus IBR z dvema izbrisanima genoma, zaradi česar je manj patogen (manj zmožen povzročiti bolezen).
HIPRABOVIS IBR MARKER LIVE lyophilisate and solvent for suspension for injection for cattle.
HIPRABOVIS IBR MARKER LIVE liofilizat in vehikel za suspenzijo za injiciranje za govedo
HIPRAMUNE T (solvent)
Hipramune T (vehikel)
Hirobriz Breezhaler 150 microgram inhalation powder, hard capsules Hirobriz Breezhaler 300 microgram inhalation powder, hard capsules Indacaterol
Hirobriz Breezhaler 150 mikrogramov prašek za inhaliranje, trde kapsule Hirobriz Breezhaler 300 mikrogramov prašek za inhaliranje, trde kapsule indakaterol
Hirobriz Breezhaler 150 microgram inhalation powder, hard capsules Indacaterol
Hirobriz Breezhaler 150 mikrogramov prašek za inhaliranje, trde kapsule indakaterol
Hirobriz Breezhaler 300 microgram capsules have a blue product code “IDL 300” printed above a blue bar and a blue company logo ) printed below the blue bar.
Kapsule Hirobriz Breezhaler 300 mikrogramov imajo nad modro črto z modro natisnjeno oznako "IDL 300", pod modro črto pa je z modro natisnjen zaščitni znak družbe ).
Hirobriz Breezhaler 300 microgram inhalation powder, hard capsules Indacaterol
Hirobriz Breezhaler 300 mikrogramov prašek za inhaliranje, trde kapsule indakaterol
Hirobriz Breezhaler capsules are only used with a Hirobriz Breezhaler inhaler and must not be swallowed.
Kapsule zdravila Hirobriz Breezhaler se uporabljajo samo z inhalatorjem Hirobriz Breezhaler in se jih ne sme pogoltniti.
Hirobriz Breezhaler has no or negligible influence on the ability to drive and use machines.
Zdravilo Hirobriz Breezhaler nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
Hirobriz Breezhaler inhaler Blister Inhaler base
inhalator Hirobriz Breezhaler pretisni omot spodnji del inhalatorja
Hirobriz Breezhaler is a medicine that contains the active substance indacaterol.
Hirobriz Breezhaler je zdravilo, ki vsebuje zdravilno učinkovino indakaterol.
Hirobriz Breezhaler is not indicated for the treatment of acute episodes of bronchospasm, i.e. as rescue therapy.
Zdravilo Hirobriz Breezhaler ni indicirano za zdravljenje akutnih epizod bronhospazma, t.j. kot zdravilo za nujne primere.
Hirobriz Breezhaler is used to keep the airways open in adults with chronic obstructive pulmonary disease (COPD).
Zdravilo Hirobriz Breezhaler se uporablja za vzdrževanje odprtih dihalnih poti pri odraslih bolnikih s kronično obstruktivno pljučno boleznijo (KOPB).
Hirobriz Breezhaler is used to make breathing easier for adult patients who have breathing difficulties due to a lung disease called chronic obstructive pulmonary disease (COPD).
Zdravilo Hirobriz Breezhaler olajša dihanje odraslim bolnikom, ki imajo težave z dihanjem zaradi pljučne bolezni z imenom kronična obstruktivna pljučna bolezen (KOPB).
Hirobriz Breezhaler must not be used in people who are hypersensitive (allergic) to indacaterol, lactose or any of the other ingredients.
Zdravila Hirobriz Breezhaler ne smejo uporabljati osebe, ki utegnejo biti preobčutljive za (alergične na) indakaterol, laktozo ali katero koli drugo sestavino zdravila.
Hirobriz Breezhaler should not be given to children or adolescents below the age of 18 years.
Otroci in mladostniki, ki so stari manj kot 18 let, ne smejo prejemati zdravila Hirobriz Breezhaler.
Hirobriz Breezhaler should not be used in asthma due to the absence of long-term outcome data in asthma with Hirobriz Breezhaler.
da se zdravila Hirobriz Breezhaler ne sme uporabljati pri astmi, ker ni podatkov o dolgoročnih rezultatih pri zdravljenju astme z zdravilom Hirobriz Breezhaler,
Hirsutism
hirsutizem
Hirsutism; rash; pruritus; chloasma
hirzutizem, izpuščaj, pruritus, kloazma
Hispanic
Latinoameričani
Hispanic/Latino Ethnicity, N (%)
Hispanska/latinskoameriška etnična pripadnost, N (%)
Histamine dihydrochloride was not teratogenic in rats or rabbits at doses resulting in several hundred- fold greater systemic exposures than the clinical exposure.
Histaminijev diklorid pri podganah ali kuncih v odmerkih z nekaj stokrat večjo sistemsko izpostavljenostjo kot pri klinični izpostavljenosti ni bil teratogen.
HISTAMINE H2 ANTAGONIST
ANTAGONIST H2
Histamine H2-receptor antagonist
področjih (odmerek
Histamine is a naturally occurring substance in the body that is involved in many processes.
Histamin je naravno prisotna snov v telesu, ki sodeluje v številnih procesih.
Histamine is a substance in the body that causes allergic symptoms.
Histamin je snov v telesu, ki povzroča alergijske simptome.
Histidine hydrochloride monohydrate Sucrose
histidin histidinijev klorid monohidrat saharoza.
Histidine Polysorbate 20 Sodium chloride Water for injections
histidin polisorbat 20 natrijev klorid voda za injiciranje
histocytic necrotising lymphadenitis (Kikuchi lymphadenitis)
histiocitni nekrotizirajoči limfadenitis (Kikuchijev limfadenitis)
Histological grade Grade1 (includes grade not assessed)
topnja (vključuje primere z neocenjeno stopnjo)
Histological response (%)b
Histološki odziv (%)b
Histological response (%)b
Parameter
Histological response2
histološki odziv2
Histological responsea,b (%)
Histološki odziva,b (%)
Histological subtype was similar in both treatment arms, with 33% hyaline vascular subtype, 23% plasmacytic subtype and 44% mixed subtype.
Histološki podtipi so bili v obeh študijskih skupinah podobni, in sicer jih je bilo 33 % hialino vaskularnega podtipa, 23% plazmacitnega podtipa in 44% mešanega podtipa.
Histologically, mild local reactions with chronic inflammation of the connective tissue and some capsule formation and collagen deposition have been seen at 3 months after administration.
Histološko so 3 mesece po implantaciji ugotovili blage lokalne reakcije s kroničnim vnetjem veznega tkiva, nastankom kapsule in odlaganjem kolagena.
Histologically, mild local reactions with chronic inflammation of the connective tissue and some capsule formation and collagen deposition have been seen at 3 months after administration.
Histološko so bile 3 mesece po prvem dajanju ugotovljen blage lokalne reakcije s kroničnim vnetjem veznega tkiva in nastanek kapsule ter kopičenje kolagena.
Histology <0.0001 4.4 times higher in adenocarcinoma than in non-adenocarcinoma
Histologija < 0,0001 4,4-krat večji pri adenokarcinomu kot pri neadenokarcinomu
historical controls
enkraten odmerek)
historical controls
glejte spodaj.
historical controls
kontrolnimi osebami iz preteklosti
historical controls suggests that
kontrolnih osebah iz preteklosti
Historical Reference Comparator
Historična referenčna primerjava
Historically Controlled Trial (25mg/kg/day)
Zgodovinsko nadzorovano preskušanje (25 mg/kg/dan)
history of a stroke, or bleeding within the brain or eye
anamnezo možganske kapi, krvavitve v možgane ali oko
History of agranulocytosis.
Anamneza agranulocitoze
History of an anaphylactic (i.e. life-threatening) reaction to any of the constituents or trace residues of eggs, chicken proteins, kanamycin and neomycin sulphate, barium sulphate, formaldehyde and cetyltrimethylammonium bromide (CTAB) of this vaccine.
Anafilatične (tj. smrtno nevarne) reakcije v anamnezi na katero koli sestavino cepiva ali ostanke jajc v sledovih, piščančje beljakovine, kanamicin in neomicinsulfat, barijev sulfat, formaldehid in cetiltrimetilamonijev bromid (CTAB) v cepivu.
History of anaphylactic reactions to the active substance, or to any of the excipients listed in section 6.1, or trace residues (formaldehyde, benzonase, sucrose, trypsin, Vero host cell protein).
Anafilaktične reakcije v pretekli anamnezi na zdravilno učinkovino ali katero koli pomožno snov, navedeno v poglavju 6.1, ali ostanke v sledeh (npr. formaldehid, benzonaza, saharoza, tripsin, beljakovine gostiteljskih celic Vero).
History of angioedema with aliskiren.
anamneza angioedema zaradi aliskirena;
History of angioedema with pirfenidone (see section 4.4).
angioedem zaradi pirfenidona v anamnezi (glejte poglavje 4.4),
History of Aplastic Anaemia or MDS (%)
Anamneza aplastične anemije ali MDS (%)
History of cardiac arrest
anamnezo zastoja srca
history of cerebrovascular accident
cerebrovaskularni inzult v preteklosti,
history of congenital bleeding diatheses
prirojena nagnjenost h krvavitvam v anamnezi
History of dental disease, poor oral hygiene, periodontal disease, invasive dental procedures (e.g. tooth extractions) and poorly fitting dentures
Zobozdravstvene bolezni v anamnezi, slaba ustna higiena, peridontalne bolezni, invazivni zobozdravstveni postopki (na primer ekstrakcija zoba) in slabo prileganje protez.
History of Erectile Dysfunction N (%)
Anamneza erektilne disfunkcije N (%)
history of head trauma
poškodba glave v anamnezi;
History of hypersensitivity to the active substance, to any of the excipients or trace residuals (e.g. neomycin) (see sections 4.4 and 6.1).
Anamneza preobčutljivosti na zdravilno učinkovino, katero koli pomožno snov ali v sledeh prisotne snovi (npr. neomicin) (glejte poglavji 4.4 in 6.1).